CI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cigna Group (CI) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show mixed signals, with bearish momentum in MACD and RSI, alongside bullish moving averages. Analysts have recently downgraded the stock, citing uncertainties in its pharmacy benefit manager transition and commercial attrition risks. Insider selling has surged significantly, and Congress trading data shows more selling than buying activity. While the stock has potential long-term opportunities in its Specialty focus, the current sentiment and risks do not align with a strong buy recommendation.
The MACD histogram is -0.465, indicating bearish momentum. RSI is at 29.408, which is neutral but leaning towards oversold territory. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 282.25, with resistance at 297.584. The stock is trading near its support level, but negative MACD and RSI suggest caution.
Bullish moving averages indicate potential long-term support. Morgan Stanley and Bernstein have raised price targets, highlighting Specialty opportunities.
Recent analyst downgrades from Barclays and Deutsche Bank cite uncertainties in the pharmacy benefit manager transition and commercial attrition risks. Insider selling has increased by 4982.25% over the last month. Congress trading data shows more selling than buying activity.
No financial performance data available for analysis.
Mixed ratings with recent downgrades from Barclays and Deutsche Bank to 'Equal Weight' and 'Hold,' respectively. Price targets have been lowered by these firms. However, Morgan Stanley and Bernstein maintain optimistic views with higher price targets, citing long-term Specialty opportunities.
